Trademark: 79181316
Word
JOINT POLISH INVESTMENT FUND FINANCING INNOVATION IN HEALTHCARE AND LIFE SCIENCES
Status
Dead
Status Code
709
Status Date
Friday, June 23, 2023
Serial Number
79181316
Registration Number
5093375
Registration Date
Tuesday, December 6, 2016
Mark Type
3000
Filing Date
Tuesday, September 29, 2015
Published for Opposition
Tuesday, September 20, 2016
Cancellation Date
Friday, June 23, 2023

Trademark Owner History
NUTRA SP. Z O.O. - Original Registrant

Classifications
36 Financial capital investment services, namely, administering the issuance, underwriting and distribution of investment and mutual funds; mutual fund investment; investment of funds for others; providing financial services with respect to securities and other financial instruments and products, namely, money management services; financial trust administration; unit trust management accounts; investment management; investment analysis; investment advice in the field of asset allocation; financial analysis; financial economic analysis; investment research; research services relating to finance; financial advice; financial investment advisory services; issuance of bonds; issuing of promissory notes for raising debt and equity capital for others; credit card factoring services; financial management; commodities financing; financing of mergers; financing of guarantees; financing of investments; providing private equity financing for companies; project financing; providing information in the field of finance; financial analysis, namely, compiling and analyzing financial statistics, data and other sources of financial information for financial purposes; stock trading; trading in bonds; trading in options; trading in futures; trading in currencies; international fund investment; providing fund investment consultation; investment by electronic means; financial investment brokerage; financial investment in the field of securities; fund investments; financial appraisals and valuations; financial custody services, namely, maintaining possession of investment assets for others for financial management purposes; arranging finance for businesses, namely, financing of loans; conducting of financial transactions, namely, investment fund transfer and transaction services; investment brokerage; professional financial consulting; financial forecasting; financial investment advisory services; capital investment consultation; financial economic advisory services; financial advisory services; investment advisory services in the field of unit trust securities; advisory services relating to financial risk management; financial investment advisory services; financial investment analysis and stock research; financial information; trusteeship representatives; trust investment services; financial risk management services; financial valuation of personal property and real estate; securing of funds in the nature of providing venture investment funding; investment of offshore utilized funds for others; venture capital fund management; management investment fund; investment share management; cash management; financial services, namely, business fundraising for others; funds investment
35 Business organization advice; analysis and research on economic activity; business information service; business advice relating to growth financing; business consultancy and advisory services; business acquisitions consultation; business merger consultation; business advice relating to franchising; business advice relating to accounting; business advisory services relating to product development; business consulting for enterprises; acquisition and merger consultation; business organization advice; business auditing consulting; business management advice; business management and organization consultancy; business advice relating to outsourcing; professional business consulting
42 Providing scientific research information in the field of pharmaceuticals; scientific research; scientific and technological services, namely, scientific research in the fields of biotechnology, pharmaceuticals, medicine, pharmaceutical and medical laboratory equipment and apparatus, drug development, medical technology, medical diagnostics, mobile health technologies and personalized health technologies
The mark consists of the black colored bold lettering words "Joint Polish Investment Fund". Below this are the black colored words "Financing Innovation in Healthcare and Life Sciences". To the left is a design comprised of two red colored incomplete squares. The left incomplete square is shaped like a tilted letter "C". The right incomplete square is shaped like a tilted backwards letter "C". The bottom portion of the right incomplete square is inside the gap of the left incomplete square.
JOINT POLISH INVESTMENT FUND FINANCING INNOVATION IN HEALTH CARE AND LIFE SCIENCES
The color(s) black and red is/are claimed as a feature of the mark.
"JOINT POLISH INVESTMENT FUND" AND "FINANCING INNOVATION IN HEALTHCARE AND LIFE SCIENCES"

Trademark Events
Apr 1, 2024
Total Invalidation Processed By The Ib
Mar 6, 2024
Generic Madrid Transaction Sent To Ib
Mar 6, 2024
Generic Madrid Transaction Created
Feb 23, 2024
Total Invalidation Of Reg Ext Protection Created
Jun 23, 2023
Cancelled Section 71
Dec 6, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 25, 2019
New Representative At Ib Received
Feb 22, 2018
New Representative At Ib Received
Jul 14, 2017
Final Decision Transaction Processed By Ib
Jun 23, 2017
New Representative At Ib Received
Mar 9, 2017
Generic Madrid Transaction Sent To Ib
Mar 9, 2017
Generic Madrid Transaction Created
Mar 6, 2017
Final Disposition Notice Created, To Be Sent To Ib
Dec 6, 2016
Registered-Principal Register
Nov 11, 2016
Notification Of Possible Opposition - Processed By Ib
Sep 20, 2016
Official Gazette Publication Confirmation E-Mailed
Sep 20, 2016
Published For Opposition
Aug 31, 2016
Notification Of Possible Opposition Sent To Ib
Aug 31, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 31, 2016
Notification Of Notice Of Publication E-Mailed
Aug 10, 2016
Approved For Pub - Principal Register
Aug 10, 2016
Teas/Email Correspondence Entered
Aug 9, 2016
Correspondence Received In Law Office
Aug 9, 2016
Teas Request For Reconsideration Received
Aug 4, 2016
Notification Of Final Refusal Emailed
Aug 4, 2016
Final Refusal E-Mailed
Aug 4, 2016
Final Refusal Written
Jul 27, 2016
Teas/Email Correspondence Entered
Jul 27, 2016
Correspondence Received In Law Office
Jul 27, 2016
Teas Response To Office Action Received
Jul 26, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 26, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 27, 2016
Refusal Processed By Ib
Feb 10, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Feb 10, 2016
Refusal Processed By Mpu
Feb 10, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Feb 9, 2016
Non-Final Action Written
Feb 9, 2016
Application Filing Receipt Mailed
Feb 3, 2016
Assigned To Examiner
Feb 3, 2016
New Application Office Supplied Data Entered
Jan 30, 2016
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24